A 2022 poll revealed that 55% of Americans believe the Fruit of the Loom logo features a cornucopia, a woven brown horn of plenty, despite the logo not actually including one. This phenomenon is an example of the Mandela effect, a collective false memory where a group of people misremember a particular event or detail. The poll also found that 25% of respondents were unsure about the logo's design, while 21% were confident that it did not include a cornucopia.

According to Amelia Tait, author of the story, which is part of MIT Technology Review's series The New Conspiracy Age, the Mandela effect is a fascinating example of how collective false memories can form and persist. "The Mandela effect is a phenomenon where a group of people remember an event or detail differently than what is recorded in history books or other sources," Tait explained. "In the case of the Fruit of the Loom logo, it's clear that many people have misremembered its design, and this has led to a sense of confusion and uncertainty."

The Mandela effect is not limited to the Fruit of the Loom logo. Many people also misremember Nelson Mandela's death, with some believing he died in prison when in fact he died in 2013 after serving as President of South Africa from 1994 to 1999. The phenomenon has been observed in other areas, including the Berenstain Bears children's book series, which many people remember being spelled "Berenstein Bears" despite the correct spelling always being "Berenstain."

In other news, researchers are making progress on developing a vaccine for the common cold. According to a recent study published in the journal Nature, scientists have identified several promising candidates for a cold vaccine, including a nasal spray that has shown promising results in clinical trials. The study's lead author, Dr. John Treanor, noted that while the vaccine is still in the early stages of development, it has the potential to revolutionize the way we treat the common cold.

"We're excited about the progress we've made so far, but we still have a lot of work to do," Dr. Treanor said. "The common cold is a complex virus, and developing a vaccine that is effective against all strains will be a challenge. However, we're optimistic that our research will lead to a breakthrough in the near future."

The development of a cold vaccine has significant implications for public health. According to the Centers for Disease Control and Prevention (CDC), the common cold is one of the most common illnesses in the United States, with millions of people affected each year. A vaccine could potentially reduce the number of cases and alleviate the burden on the healthcare system.

While a cold vaccine is still in the experimental stages, researchers are hopeful that it will become a reality in the near future. "We're making progress, and we're optimistic that we'll have a vaccine available soon," Dr. Treanor said. "It's an exciting time for cold research, and we're looking forward to seeing the impact that a vaccine will have on public health."